Nanoformulation Strategies in Drug Development: Overcoming Biopharmaceutical Limitations

Abstract

Nanoformulations have revolutionized drug development by enabling precise drug targeting, improved solubility, and controlled release. This paper presents a comprehensive review of nanoformulation strategies, including liposomes, solid lipid nanoparticles, dendrimers, and polymeric nanoparticles. It discusses the rationale behind nanosizing poorly soluble drugs, enhancing cellular uptake, and reducing systemic toxicity. The paper also highlights challenges such as nanoparticle aggregation, toxicity concerns, and regulatory hurdles in translating nanomedicines from lab to clinical use. Mechanistic insights into drug release kinetics, pharmacokinetics, and bio-distribution are provided, alongside successful case studies demonstrating clinical efficacy. Future perspectives focus on integrating nanotechnology with personalized medicine and advanced imaging techniques for targeted therapy.

KEYWORDS: Nanotechnology, Nanoformulations, Targeted Drug Delivery, Bioavailability, Controlled Release